Background Whether young adults who are infected with SARS-CoV-2 are at risk of subsequent
infection is uncertain. We investigated the risk of subsequent SARS-CoV-2 infection …

Background & Aims: Infectious gastroenteritis (IGE) is known to exacerbate previously
diagnosed inflammatory bowel disease (IBD). However, limited data are available describing a …

Background & Aims Biomarkers are needed to identify patients at risk for development of
inflammatory bowel diseases. We aimed to identify serum biomarkers of Crohn’s disease and …

Several candidate vaccines against Shigella spp. are in development, but the lack of a clear
correlate of protection from challenge with the induction of adequate immune responses …

Background Patients with Crohn's disease ( CD ) have serologic responses to various
microbial antigens. Serologic markers are associated with aggressive forms of disease and can …

… Riddle; analysis and interpretation of data and drafting of the manuscript: Chad K. Porter
and Mark S. Riddle; providing important intellectual content: Joseph A. Murray; all authors were …

… Specific author contributions: Chad K. … Chad K. Porter and Mark S. Riddle were
involved in the analysis and interpretation of data and drafting of the paper. Brooks D. …

Diarrhoeal disease attributable to enterotoxigenic Escherichia coli (ETEC) causes substantial
morbidity and mortality predominantly in paediatric populations in low- and middle-income …

The capsule polysaccharide (CPS) of Campylobacter jejuni is one of the few identified
virulence determinants of this important human pathogen. Since CPS conjugate vaccines have …

Background Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in
children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine …